Literature DB >> 12819408

Mammographic and clinical predictors of drainage patterns in breast lymphoscintigrams obtained during sentinel node procedures.

Dominick Lamonica1, Stephen B Edge, Thelma Hurd, Gary Proulx, Paul C Stomper.   

Abstract

PURPOSE: The authors' purpose was to explore the association between mammographic findings and drainage patterns on lymphoscintigrams obtained during sentinel node procedures for breast carcinoma.
MATERIALS AND METHODS: From July 1997 to March 2000, 132 patients with breast cancer who were included in a prospective mammography-pathology correlation and staging database were imaged 2 hours after perilesional injection of 1 mCi filtered (0. 22 microm) Tc-99m sulfur colloid (4 ml volume) before sentinel node procedures.
RESULTS: Sixty-four percent of the scans showed axillary drainage only, 9% showed axillary and internal mammary drainage, and 4% revealed internal mammary drainage only. Twenty-three percent of scans showed no drainage. Of the patients who showed drainage, 17% showed drainage to the internal mammary basin, and 5% showed this exclusively. Internal mammary drainage was seen in 18% (10 of 57) of lateral, 21% (6 of 29) of medial, and 14% (1 of 7) of subareolar lesions (P = NS). No drainage was seen in 22% of patients with predominantly fatty mammographic parenchymal density (>50%) compared with only 8% of patients with predominantly dense (>50%) parenchyma (P < 0.05). Failure to show drainage was more common in women older than 50 years (P < 0.05). Axillary sentinel nodes were identified surgically in 73% of patients with negative scan findings. There was no significant association between scintigraphic drainage and mammographic soft tissue tumor size and appearance, histologic findings, or axillary node status.
CONCLUSIONS: Dense mammographic parenchyma and age less than 50 years are associated with identification of lymphatic drainage on lymphoscintigrams performed before sentinel node procedures in 91% to 92% of patients. Internal mammary drainage, present in 18% of lateral and 21% of medial lesions, may direct therapy to include internal mammary lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819408     DOI: 10.1097/00003072-200307000-00005

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  Internal Mammary Sentinel Node Biopsy in Breast Cancer. Is it Indicated?

Authors:  R Maráz; G Boross; J Pap-Szekeres; M Rajtár; E Ambrózay; G Cserni
Journal:  Pathol Oncol Res       Date:  2013-08-11       Impact factor: 3.201

2.  Internal mammary lymph node recurrence: rare but characteristic metastasis site in breast cancer.

Authors:  Lei Chen; Yajia Gu; Shiangjiin Leaw; Zhonghua Wang; Peihua Wang; Xichun Hu; Jiayi Chen; Jingsong Lu; Zhimin Shao
Journal:  BMC Cancer       Date:  2010-09-07       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.